Tandem Diabetes Care (TNDM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 940,203 | 747,718 | 801,217 | 702,799 | 498,830 |
| Cost of Goods | 450,629 | 380,028 | 388,231 | 326,584 | 238,310 |
| Gross Profit | 489,574 | 367,690 | 412,986 | 376,215 | 260,520 |
| Operating Expenses | 589,330 | 600,948 | 506,065 | 354,146 | 268,787 |
| Operating Income | -99,127 | -233,230 | -92,848 | 22,653 | -7,957 |
| Interest Expense | 7,415 | 9,882 | 6,208 | 6,040 | 12,805 |
| Other Income | 14,672 | 22,858 | 6,204 | -712 | -15,520 |
| Pre-tax Income | -91,870 | -220,254 | -92,852 | 15,901 | -36,282 |
| Income Tax | 4,155 | 2,357 | 1,742 | 335 | -1,900 |
| Net Income Continuous | -96,025 | -222,611 | -94,594 | 15,566 | -34,382 |
| Net Income | $-96,025 | $-222,611 | $-94,594 | $15,566 | $-34,382 |
| EPS Basic Total Ops | -1.47 | -3.43 | -1.47 | 0.25 | -0.56 |
| EPS Basic Continuous Ops | -1.47 | -3.43 | -1.47 | 0.25 | -0.56 |
| EPS Diluted Total Ops | -1.47 | -3.43 | -1.47 | 0.24 | -0.56 |
| EPS Diluted Continuous Ops | -1.47 | -3.43 | -1.47 | 0.24 | -0.56 |
| EPS Diluted Before Non-Recurring Items | -1.91 | -1.57 | -0.74 | 0.26 | -0.39 |
| EBITDA(a) | $-82,752 | $-211,724 | $-72,435 | $38,590 | $11,294 |